AU3069192A - Hiv protease inhibitors containing guanidine - Google Patents

Hiv protease inhibitors containing guanidine

Info

Publication number
AU3069192A
AU3069192A AU30691/92A AU3069192A AU3069192A AU 3069192 A AU3069192 A AU 3069192A AU 30691/92 A AU30691/92 A AU 30691/92A AU 3069192 A AU3069192 A AU 3069192A AU 3069192 A AU3069192 A AU 3069192A
Authority
AU
Australia
Prior art keywords
protease inhibitors
hiv protease
inhibitors containing
containing guanidine
guanidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30691/92A
Inventor
John Gerald Gleason
Robert Thomas Lum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU3069192A publication Critical patent/AU3069192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU30691/92A 1991-11-01 1992-10-30 Hiv protease inhibitors containing guanidine Abandoned AU3069192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78643591A 1991-11-01 1991-11-01
US786435 1991-11-01

Publications (1)

Publication Number Publication Date
AU3069192A true AU3069192A (en) 1993-06-07

Family

ID=25138568

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30691/92A Abandoned AU3069192A (en) 1991-11-01 1992-10-30 Hiv protease inhibitors containing guanidine

Country Status (7)

Country Link
EP (1) EP0610431A1 (en)
JP (1) JPH07501056A (en)
AU (1) AU3069192A (en)
MX (1) MX9206294A (en)
PT (1) PT101026A (en)
WO (1) WO1993009132A1 (en)
ZA (1) ZA928396B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430150A (en) * 1992-12-16 1995-07-04 American Cyanamid Company Retroviral protease inhibitors
US5455351A (en) * 1993-12-13 1995-10-03 Abbott Laboratories Retroviral protease inhibiting piperazine compounds
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3809145A1 (en) * 1988-03-18 1989-09-28 Merck Patent Gmbh AMINOSAEUREDERIVATE
DE3812328A1 (en) * 1988-04-14 1989-10-26 Merck Patent Gmbh AMINOSAEUREDERIVATE
IL91307A0 (en) * 1988-08-24 1990-03-19 Merck & Co Inc Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them

Also Published As

Publication number Publication date
EP0610431A1 (en) 1994-08-17
WO1993009132A1 (en) 1993-05-13
MX9206294A (en) 1993-08-01
JPH07501056A (en) 1995-02-02
ZA928396B (en) 1993-05-12
PT101026A (en) 1994-05-31

Similar Documents

Publication Publication Date Title
ZA929869B (en) Hiv protease inhibitors
KR100190517B1 (en) Hiv protease inhibitors
AU9122391A (en) Hiv protease inhibitors
PH31249A (en) Inhibitors of hiv protease.
AU4091093A (en) Alpha-alumina
PL307858A1 (en) Sulphonamidic inhibitors of aspartilic hiv protease
IL102534A0 (en) Retroviral protease inhibitors
AU6135294A (en) Piperazine derivatives as hiv protease inhibitors
AU5069993A (en) Retroviral protease inhibitors
EP0480714A3 (en) Hiv protease inhibitors having symmetrical structure
AU7131991A (en) Hiv protease inhibiting agents
AUPM982594A0 (en) HIV protease inhibitors
AU7132091A (en) Hiv protease inhibitors containing derived amino acid units
AU7132391A (en) Hiv protease inhibitors
AU7732691A (en) Hiv protease inhibitors and processes for their preparation
AU6828894A (en) Hiv protease inhibitors
EP0594586A4 (en) Hiv protease inhibitors
AU2642492A (en) Peptide isoters containing a heterocycle as h.i.v. inhibitors
AU3735793A (en) Retroviral protease inhibitors
AU3069192A (en) Hiv protease inhibitors containing guanidine
EP0566237A3 (en) Retroviral protease inhibitors.
EP0575500A4 (en) Hiv protease inhibitors
AU2894192A (en) Cns active tetrahydrobenzothienopyridines
GB9318445D0 (en) Hiv protease in inhibitor compounds
AU9177391A (en) Pallet